Coronavirus (COVID-19)
Learn more
March 13, 2013
Location: The Hospital of Central Connecticut
Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients with Asymptomatic HighRisk Smoldering Multiple Myeloma.
Get the latest healthcare news directly in your inbox.
Sign up for text alerts / Text MoreLife to 31996.